Medically Reviewed by Mark Hrymoc, M.D., Chief Medical Officer, double-board certified in General & Addiction Psychiatry
Substance use disorders are complex medical conditions that affect the brain, behavior, and emotional regulation. While addiction is sometimes misunderstood as a lack of willpower or a purely behavioral issue, decades of research have shown that it is a chronic, relapsing condition driven by neurobiological changes and psychological vulnerability. Psychiatry plays a central role in treating substance use disorders by addressing both the biological mechanisms of addiction and the mental health conditions that often accompany it. Through evidence-based approaches, medication management, and integrated care, psychiatry helps individuals achieve stabilization, reduce relapse risk, and support long-term recovery.
Understanding Substance Use Disorders as Medical Conditions
Substance use disorders occur when repeated use of alcohol or drugs leads to changes in brain circuits involved in reward, motivation, stress, and self-control. These changes make it difficult to stop using substances despite harmful consequences. Over time, substances become prioritized over relationships, work, health, and personal values.
Addiction affects multiple neurotransmitter systems, including dopamine, glutamate, and gamma-aminobutyric acid (GABA). These systems influence pleasure, learning, impulse control, and emotional regulation. As addiction progresses, the brain becomes less responsive to natural rewards and more sensitive to stress and substance-related cues. This neurobiological shift explains why relapse can occur even after long periods of abstinence and why comprehensive medical treatment is often necessary.
Why Psychiatry Is Essential in Addiction Treatment
Psychiatry brings a medical and diagnostic framework to substance use disorder treatment. Psychiatrists are trained to evaluate complex symptom patterns, distinguish between primary psychiatric conditions and substance-induced symptoms, and develop individualized treatment plans.
Many people with substance use disorders also have co-occurring mental health conditions such as depression, anxiety disorders, bipolar disorder, post-traumatic stress disorder, or attention-deficit disorders. These conditions can precede substance use, emerge as a result of it, or worsen during periods of use and withdrawal. Without addressing both addiction and mental health together, treatment outcomes are often limited.
Psychiatric care helps clarify these interactions and ensures that both conditions are treated simultaneously rather than in isolation.
Comprehensive Psychiatric Evaluation in Addiction Care
Treatment typically begins with a comprehensive psychiatric evaluation. This assessment explores substance use history, including types of substances used, frequency, duration, patterns of escalation, and previous attempts to quit. Withdrawal symptoms, cravings, and triggers are also assessed.
Equally important is evaluating mental health history, trauma exposure, medical conditions, sleep patterns, and social stressors. Family history of addiction or psychiatric illness can offer insight into genetic and environmental risk factors.
This thorough evaluation helps determine the severity of the substance use disorder, identify co-occurring conditions, and guide appropriate treatment intensity. It also reduces the risk of misdiagnosis, such as mistaking substance-induced mood symptoms for a primary mood disorder or overlooking underlying trauma.
Medication in the Treatment of Substance Use Disorders
Medication plays a critical role in addiction psychiatry. When used appropriately, medications can reduce cravings, ease withdrawal symptoms, stabilize brain chemistry, and lower the risk of relapse. Medication is not a replacement for therapy or recovery support, but it can significantly improve outcomes when combined with psychosocial treatment.
Medications for Alcohol Use Disorder
Several medications are approved for the treatment of alcohol use disorder. Naltrexone reduces the rewarding effects of alcohol and helps decrease cravings. Acamprosate supports brain chemical balance during abstinence and reduces the risk of relapse. Disulfiram creates an aversive reaction to alcohol, although it is used less frequently due to adherence challenges.
Psychiatrists determine which medication is appropriate based on medical history, liver function, treatment goals, and individual response. These medications can help individuals reduce or stop drinking while engaging more fully in therapy and recovery planning.
Medications for Opioid Use Disorder
Opioid use disorder is associated with a high risk of overdose and relapse, making medication-assisted treatment especially important. Buprenorphine, methadone, and extended-release naltrexone are evidence-based medications that reduce cravings and withdrawal symptoms while stabilizing brain function.
Research has consistently shown that individuals receiving medication for opioid use disorder have lower rates of overdose, improved treatment retention, and better overall outcomes compared to those who receive behavioral treatment alone. Psychiatry plays a key role in initiating, monitoring, and adjusting these medications as part of comprehensive care.
Medications for Other Substance Use Disorders
While fewer medications are approved for stimulant or cannabis use disorders, psychiatric care still plays an important role. Certain antidepressants, mood stabilizers, or off-label medications may help reduce cravings, address underlying mood symptoms, or improve impulse control. Ongoing research continues to explore new pharmacologic options for these conditions.
Treating Co-Occurring Mental Health Conditions
Co-occurring mental health disorders are the norm rather than the exception in addiction treatment. Depression, anxiety, trauma-related disorders, and mood instability can drive substance use as a form of self-medication. At the same time, substance use can worsen psychiatric symptoms by disrupting sleep, mood regulation, and cognitive functioning.
Psychiatry addresses this bidirectional relationship by treating both conditions together. For example, stabilizing mood in bipolar disorder can reduce the urge to use substances during depressive or manic episodes. Treating anxiety disorders can decrease reliance on alcohol or sedatives for relief. Trauma-informed psychiatric care recognizes how past experiences influence both addiction and emotional regulation.
Integrated treatment reduces the risk of relapse and supports sustained recovery by addressing the full clinical picture.
The Role of Therapy in Psychiatric Addiction Care
While medication addresses biological aspects of addiction, psychotherapy targets behavioral patterns, emotional processing, and coping skills. Psychiatry often works alongside therapy to ensure a coordinated approach.
Cognitive-behavioral therapy helps individuals identify triggers, challenge unhelpful beliefs, and develop strategies for managing cravings. Motivational interviewing supports engagement and helps clarify personal reasons for change. Trauma-focused therapies address underlying experiences that contribute to substance use.
Psychiatric oversight ensures that therapy is aligned with medication management and adjusted as symptoms evolve.
Levels of Care and Treatment Planning
Psychiatry helps determine the appropriate level of care based on severity, safety, and support needs. Some individuals benefit from outpatient treatment with medication management and therapy. Others may require intensive outpatient programs, partial hospitalization, residential treatment, or medically supervised detoxification.
Treatment plans are not static. As individuals stabilize, care may step down in intensity. If relapse or symptom escalation occurs, care can be adjusted accordingly. This flexibility is a key strength of psychiatric involvement in addiction treatment.
Addressing Relapse as Part of the Recovery Process
Relapse is a common part of substance use disorders and does not mean treatment has failed. Psychiatry frames relapse as a signal that treatment needs adjustment rather than a moral failure.
Psychiatrists help identify relapse triggers, assess whether medications need modification, and address emerging mental health symptoms. This medical approach reduces shame and encourages continued engagement in care. Long-term recovery often involves learning from setbacks and refining treatment strategies over time.
Reducing Stigma Through Medical Care
One of the most important roles of psychiatry in addiction treatment is reducing stigma. Viewing addiction as a medical condition supported by neuroscience helps shift treatment away from punishment or judgment and toward compassion and evidence-based care.
Psychiatric involvement reinforces that substance use disorders deserve the same level of medical attention as other chronic illnesses. This perspective encourages individuals to seek help earlier and remain engaged in treatment longer.
Long-Term Recovery and Psychiatric Follow-Up
Recovery from substance use disorders is an ongoing process that extends beyond initial stabilization. Psychiatric follow-up supports long-term success by monitoring mental health, adjusting medications as needed, and addressing life stressors that arise during recovery.
As individuals rebuild routines, relationships, and goals, psychiatric care helps maintain balance and prevent recurrence of symptoms that could trigger relapse. For many, ongoing medication management and periodic check-ins provide a sense of continuity and support.
When to Seek Psychiatric Help for Substance Use
Professional psychiatric care may be helpful when substance use is difficult to control, causes distress or impairment, or is accompanied by mental health symptoms. It is especially important to seek help if withdrawal symptoms are severe, cravings feel overwhelming, or substance use is being used to manage emotional pain.
Early intervention improves outcomes and reduces the risk of medical complications. Psychiatric care can also support individuals who are unsure whether their substance use meets criteria for a disorder but are concerned about its impact.
Seek Support
Psychiatry plays a vital role in treating substance use disorders by addressing the biological, psychological, and emotional aspects of addiction. Through comprehensive evaluation, medication management, and integrated mental health care, psychiatric treatment supports recovery and long-term stability. Substance use disorders are treatable conditions, and effective care can help individuals regain control and rebuild their lives. Licensed psychiatrists and mental health professionals can guide this process with evidence-based, compassionate care. To learn more about addiction psychiatry and substance use disorder treatment in Los Angeles, call (310) 601-9999 or visit www.mentalhealthctr.com.
References
- American Psychiatric Association. (2022). DSM-5-TR: Diagnostic and Statistical Manual of Mental Disorders.
- Volkow, N. D., et al. (2016). Neurobiologic advances from the brain disease model of addiction. New England Journal of Medicine, 374(4), 363–371.
- National Institute on Drug Abuse. (2023). Drugs, brains, and behavior: The science of addiction.
- McLellan, A. T., et al. (2000). Drug dependence, a chronic medical illness. JAMA, 284(13), 1689–1695.
- Carroll, K. M., & Weiss, R. D. (2017). The role of behavioral interventions in drug abuse treatment. American Journal of Psychiatry, 174(8), 694–700.
- Mattick, R. P., et al. (2014). Buprenorphine maintenance versus placebo. Cochrane Database of Systematic Reviews, 2, CD002207.
- Anton, R. F., et al. (2006). Combined pharmacotherapies and behavioral interventions for alcohol dependence. JAMA, 295(17), 2003–2017.
- SAMHSA. (2023). Medications for opioid use disorder.
- Brady, K. T., et al. (2017). Co-occurring substance use and mental disorders. Journal of Clinical Psychiatry, 78(8), e906–e912.
- Kosten, T. R., & George, T. P. (2002). The neurobiology of opioid dependence. Science & Practice Perspectives, 1(1), 13–20.
